Benefits and underutilization of ITB therapy for multiple sclerosis

Published February 5, 2011

Benefits and underutilization of ITB therapy for multiple sclerosis
A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.
Read more on News-Medical-Net

Blue Cross and Blue Shield of Minnesota, American Cancer Society receive CEO Cancer Gold Standard accreditation
Blue Cross and Blue Shield of Minnesota and the American Cancer Society – High Plains Division have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Read more on News-Medical-Net

Budget captive to prison costs
Higher-education funding likely will be among the wide array of programs to receive less funding in the next state budget. It’s worth noting as the administration and Legislature begin the process that the cost of every inmate in a Pennsylvania state pri
Read more on The Pottsville Republican & Herald